301 results on '"Gravas, S."'
Search Results
2. Prostatic inflammation: a potential treatment target for male LUTS due to benign prostatic obstruction
3. New therapeutic strategies for the treatment of male lower urinary tract symptoms
4. Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia
5. LOWER URINARY TRACT SYMPTOMS AS RISK FACTOR FOR CARDIOVASCULAR EVENTS IN MEN: A SYSTEMATIC REVIEW AND META-ANALYSIS OF FIVE LONGITUDINAL TRIALS: MP35-03
6. A Systematic Review of Patients’ Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract Symptoms
7. Sexual function in pre- and post-menopausal women with obstructive sleep apnea syndrome
8. A systematic review of patients’ values, preferences and expectations for the diagnosis and treatment of male Lower Urinary Tract Symptoms (LUTS)
9. A new risk calculator to predict changes in IPSS score and risk of AUR / BPH-related surgery in BPH patients with moderate-severe symptoms at risk of disease progression receiving placebo, dutasteride, tamsulosin, or combination therapy
10. Age-Related Mental Health Consequences of COVID-19: A Global Perspective
11. The use of tamsulozin as adjunctive treatment after ESWL in patients with distal ureteral stone: do we really need it?: Results from a randomised study
12. CAN METABOLIC SYNDROME AFFECT THE EFFICACY OUTCOMES OF COMBINATION THERAPY WITH DAILY TADALAFIL 5MG PLUS TAMSULOSIN 0.4MG IN MEN WITH LUTS AND ED?
13. Cefixime versus prulifloxacin as a prophylactic treatment for prostate biopsy: A randomized study
14. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era
15. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era
16. Impact of COVID-19 on Urology Practice: A Global Perspective and Snapshot Analysis
17. Cross-continental comparison of safety and protection measures amongst urologists during COVID-19
18. Impact of COVID-19 on medical education: introducinghomo digitalis
19. Prioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines
20. BASSONʼS CIRCULAR SEXUAL RESPONSE MODEL IS ACCOMPANIED WITH WORSE SEXUAL FUNCTIONING AND HIGHER SEXUAL DISTRESS COMPARED WITH LINEAR SEXUAL RESPONSE MODELS: PS-02-005
21. Perioperative antithrombotic (antiplatelet and anticoagulant) therapy in urological practice - a critical assessment and summary of the current clinical practice guidelines
22. Ausgedehnte Steinbildung in der Prostataloge nach Adenomenukleation: Endourologische Kombinationstherapie zur Behandlung dieses interessanten Falles
23. Present Practice and Development of Minimally Invasive Techniques, Imaging and Training in European Urology: Results of a Survey of the European Society of Uro-Technology (ESUT)
24. Efficacy of prophylactic administration of prurifloxacin vs. cefixime in patients undergoing ultrasound guided prostate biopsy: A prospective randomized study
25. The impact of Enhanced Recovery After Surgery protocol on postoperative pain management in the era of opioid crisis: The post-chemotherapy open RPLND paradigm
26. Management of urinary retention in patients with benign prostatic obstruction: A systematic review and meta-analysis
27. BCL-2 FAMILY MEMBERS EXPRESSION DURING RAT PROSTATE DEVELOPMENT IN THE PRESENCE OR ABSENCE OF TESTICULAR ANDROGENS
28. MUC1 MUCIN EXPRESSION IN BLADDER CANCER: CORRELATION WITH HISTOPATHOLOGICAL DATA
29. BASIC FIBROBLAST GROWTH FACTOR IN URINE OF BLADDER CANCER PATIENTS
30. HEAT SHOCK PROTEIN EXPRESSION IN BLADDER CANCER: CORRELATION WITH HISTOPATHOLOGICAL DATA
31. INTRAVESICAL ADMINISTRATION OF AMYGDALIN IN BLADDER CANCER PATIENTS
32. Systematic review of the performance of non-invasive tests in diagnosing bladder outlet obstruction in men with lower urinary tract symptoms
33. PT201 - Perioperative antithrombotic (antiplatelet and anticoagulant) therapy in urological practice - a critical assessment and summary of the current clinical practice guidelines
34. News From Clinical Research Office of the Endourological Society (CROES)
35. News From Clinical Research Office of the Endourological Society (CROES)
36. Intravesical hyaluronic acid and chondroitin sulfate (Ialuril™) replenishment therapy for postradiation cystitis of prostate cancer: Results of a prospective pilot study
37. Categorisation of Complications and Validation of the Clavien Score for Percutaneous Nephrolithotomy
38. PT166 - Management of urinary retention in patients with benign prostatic obstruction: A systematic review and meta-analysis
39. 1018 - The impact of Enhanced Recovery After Surgery protocol on postoperative pain management in the era of opioid crisis: The post-chemotherapy open RPLND paradigm
40. Tumor size and T stage correlate independently with recurrence and progression in high-risk non-muscle-invasive bladder cancer patients treated with adjuvant BCG
41. Clinical Research Office of the Endourological Society
42. MP35-03 LOWER URINARY TRACT SYMPTOMS AS RISK FACTOR FOR CARDIOVASCULAR EVENTS IN MEN: A SYSTEMATIC REVIEW AND META-ANALYSIS OF FIVE LONGITUDINAL TRIALS
43. Postoperative infection rates in patients with a negative baseline urine culture undergoing ureteroscopic stone removal: a matched case-control analysis on antibiotic prophylaxis from the CROES URS global study
44. PT012 - Systematic review of the performance of non-invasive tests in diagnosing bladder outlet obstruction in men with lower urinary tract symptoms
45. Postoperative infection rates in low risk patients undergoing percutaneous nephrolithotomy with and without antibiotic prophylaxis: A matched case control study
46. Molecular pathogenesis of non muscle-invasive bladder cancer: Implications for novel targeted therapies
47. 807 Intravesical hyaluronic acid and chondroitin sulfate (Ialuril™) replenishment therapy for postradiation cystitis of prostate cancer: Results of a prospective pilot study
48. Systemic therapy of metastatic bladder cancer in the molecular era: Current status and future promise
49. Global URS study: A prospective international observational study on indications and perioperative outcomes
50. News from the Publication Office of CROES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.